BVF Inc’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-441,528
| Closed | -$18.5M | – | 56 |
|
|
2024
Q2 | $18.5M | Sell |
441,528
-2,478,290
| -85% | -$104M | 0.52% | 34 |
|
|
2024
Q1 | $110M | Sell |
2,919,818
-1,660,000
| -36% | -$62.5M | 3.02% | 6 |
|
|
2023
Q4 | $49.1M | Hold |
4,579,818
| – | – | 1.23% | 21 |
|
|
2023
Q3 | $46.2M | Buy |
4,579,818
+472,873
| +12% | +$4.77M | 1.24% | 22 |
|
|
2023
Q2 | $48.7M | Buy |
4,106,945
+2,521,268
| +159% | +$29.9M | 1.36% | 21 |
|
|
2023
Q1 | $19.2M | Buy |
1,585,677
+115,343
| +8% | +$1.4M | 0.7% | 37 |
|
|
2022
Q4 | $19.4M | Hold |
1,470,334
| – | – | 0.82% | 38 |
|
|
2022
Q3 | $19.9M | Hold |
1,470,334
| – | – | 0.82% | 39 |
|
|
2022
Q2 | $18M | Buy |
1,470,334
+327,994
| +29% | +$4M | 0.87% | 35 |
|
|
2022
Q1 | $16.4M | Buy |
1,142,340
+125,026
| +12% | +$1.79M | 0.66% | 39 |
|
|
2021
Q4 | $20.1M | Hold |
1,017,314
| – | – | 0.73% | 40 |
|
|
2021
Q3 | $22M | Sell |
1,017,314
-159,367
| -14% | -$3.45M | 0.86% | 33 |
|
|
2021
Q2 | $29.4M | Buy |
+1,176,681
| New | +$29.4M | 1.1% | 23 |
|